World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02792556
Date of registration: 02/06/2016
Prospective Registration: Yes
Primary sponsor: Hospices Civils de Lyon
Public title: Urine Pregnancy Test Compared to Transvaginal Ultrasound (CHECK-TOP). CHECK-TOP
Scientific title: Evaluation of Urine Pregnancy Test, CHECK TOP Test, Compared to Transvaginal Ultrasound During Control Visit Post Drug Abortion (CHECK-TOP).
Date of first enrolment: September 2016
Target sample size: 300
Recruitment status: Unknown status
URL:  https://clinicaltrials.gov/show/NCT02792556
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
France
Contacts
Name:     Corine REBELLE, MD
Address: 
Telephone: +33 4 72 07 16 63
Email: corine.rebelle@chu-lyon.fr
Affiliation: 
Name:     Corinne REBELLE
Address: 
Telephone: +33 4 72 07 16 63
Email: corine.rebelle@chu-lyon.fr
Affiliation: 
Key inclusion & exclusion criteria

- Inclusion Criteria:

- Women =18 years of age

- Undergoing drug abortion in Orthogenic Departement, Croix-Rousse Hospital, Lyon

- Intrauterine pregnancy, single or multiple, until 8 weeks of amenorrhea

- Agreeing to participate in the study after receiving information note

- Affiliated to a social security system

- Not subject to a measure of legal protection

- Exclusion Criteria:

- Women <18 years

- Ineligible patient to drug abortion

- Patient practicing a surgical abortion



Age minimum: 18 Years
Age maximum: N/A
Gender: Female
Health Condition(s) or Problem(s) studied
Drug Abortion
Intervention(s)
Device: Urine pregnancy test
Primary Outcome(s)
Negative predictive value of urine pregnancy test CHECK TOP [Time Frame: During control visit post drug abortion, after transvaginal ultrasound (at day14 or day21)]
Secondary Outcome(s)
Positive predictive value of urine pregnancy test Check Top [Time Frame: During control visit post drug abortion, after transvaginal ultrasound (at day14 or day21)]
Acceptability of urine pregnancy test Check Top by patients. [Time Frame: During control visit post drug abortion, after transvaginal ultrasound (at day14 or day21)]
Sensibility of urine pregnancy test Check Top [Time Frame: During control visit post drug abortion, after transvaginal ultrasound (at day14 or day21)]
Specificity of urine pregnancy test Check Top [Time Frame: During control visit post drug abortion, after transvaginal ultrasound (at day14 or day21)]
Secondary ID(s)
69HCL16_0263
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history